Literature DB >> 24567145

ALK5 inhibition blocks TGFβ-induced CCN1 expression in human foreskin fibroblasts.

Katherine Thompson1, Hannah Murphy-Marshman, Andrew Leask.   

Abstract

The potent profibrotic cytokine TGFβ induces connective tissue growth factor (CCN2/CTGF) is induced in fibroblasts in a fashion sensitive to SB-431542, a specific pharmacological inhibitor of TGFβ type I receptor (ALK5). In several cell types, TGFβ induces CCN1 but suppresses CCN3, which opposes CCN1/CCN2 activities. However, whether SB-431542 alters TGFβ-induced CCN1 or CCN3 in human foreskin fibroblasts in unclear. Here we show that TGFβ induces CCN1 but suppresses CCN3 expression in human foreskin fibroblasts in a SB-431542-sensitive fashion. These results emphasize that CCN1/CCN2 and CCN3 are reciprocally regulated and support the notion that blocking ALK5 or addition of CCN3 may be useful anti-fibrotic approaches.

Entities:  

Year:  2014        PMID: 24567145      PMCID: PMC3972393          DOI: 10.1007/s12079-014-0229-7

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.782


  34 in total

1.  Gadolinium-induced fibrosis is counter-regulated by CCN3 in human dermal fibroblasts: a model for potential treatment of nephrogenic systemic fibrosis.

Authors:  Bruce L Riser; Narasimharao Bhagavathula; Patricia Perone; Kendra Garchow; Yiru Xu; Gary J Fisher; Feridoon Najmabadi; Durga Attili; James Varani
Journal:  J Cell Commun Signal       Date:  2012-05-31       Impact factor: 5.782

Review 2.  The modular architecture of a new family of growth regulators related to connective tissue growth factor.

Authors:  P Bork
Journal:  FEBS Lett       Date:  1993-07-26       Impact factor: 4.124

3.  Antagonistic effect of the matricellular signaling protein CCN3 on TGF-beta- and Wnt-mediated fibrillinogenesis in systemic sclerosis and Marfan syndrome.

Authors:  Raphael Lemaire; Giuseppina Farina; Julie Bayle; Michael Dimarzio; Sarah A Pendergrass; Ausra Milano; Bernard Perbal; Michael L Whitfield; Robert Lafyatis
Journal:  J Invest Dermatol       Date:  2010-02-25       Impact factor: 8.551

4.  Anti-fibrotic effect of CCN3 accompanied by altered gene expression profile of the CCN family.

Authors:  Tarek Abd El Kader; Satoshi Kubota; Danilo Janune; Takashi Nishida; Takako Hattori; Eriko Aoyama; Bernard Perbal; Takuo Kuboki; Masaharu Takigawa
Journal:  J Cell Commun Signal       Date:  2012-10-14       Impact factor: 5.782

5.  Transforming growth factor β controls CCN3 expression in nucleus pulposus cells of the intervertebral disc.

Authors:  Cassie M Tran; Harvey E Smith; Aviva Symes; Laure Rittié; Bernard Perbal; Irving M Shapiro; Makarand V Risbud
Journal:  Arthritis Rheum       Date:  2011-10

6.  CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC.

Authors:  Youjun Chen; Ingrid E Blom; Susan Sa; Roel Goldschmeding; David J Abraham; Andrew Leask
Journal:  Kidney Int       Date:  2002-10       Impact factor: 10.612

7.  SB-431542 inhibition of scar formation after filtration surgery and its potential mechanism.

Authors:  Yi-qin Xiao; Kun Liu; Jian-feng Shen; Guo-tong Xu; Wen Ye
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-20       Impact factor: 4.799

8.  CCN2 is necessary for adhesive responses to transforming growth factor-beta1 in embryonic fibroblasts.

Authors:  Xu Shi-wen; Lee Anne Stanton; Laura Kennedy; Daphne Pala; Yunliang Chen; Sarah L Howat; Elisabetta A Renzoni; David E Carter; George Bou-Gharios; Richard J Stratton; Jeremy D Pearson; Frank Beier; Karen M Lyons; Carol M Black; David J Abraham; Andrew Leask
Journal:  J Biol Chem       Date:  2006-02-16       Impact factor: 5.157

9.  Regulation of CCN2 mRNA expression and promoter activity in activated hepatic stellate cells.

Authors:  Andrew Leask; Shaoqiong Chen; Daphne Pala; David R Brigstock
Journal:  J Cell Commun Signal       Date:  2008-09-17       Impact factor: 5.782

10.  Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio-marker of fibroproliferative disease?

Authors:  Andrew Leask; Sunil K Parapuram; Xu Shi-Wen; D J Abraham
Journal:  J Cell Commun Signal       Date:  2009-01-21       Impact factor: 5.782

View more
  5 in total

1.  Molecular signatures for CCN1, p21 and p27 in progressive mantle cell lymphoma.

Authors:  Afak Rasheed Salman Zaidi; Sadie Dresman; Charlotte Burt; Simon Rule; Lynn McCallum
Journal:  J Cell Commun Signal       Date:  2018-11-21       Impact factor: 5.782

Review 2.  Conjunction junction, what's the function? CCN proteins as targets in fibrosis and cancers.

Authors:  Andrew Leask
Journal:  Am J Physiol Cell Physiol       Date:  2020-03-04       Impact factor: 4.249

3.  CCN2 requires TGF-β signalling to regulate CCAAT/enhancer binding proteins and inhibit fat cell differentiation.

Authors:  William W C Song; Susan V McLennan; Charmaine Tam; Paul F Williams; Robert C Baxter; Stephen M Twigg
Journal:  J Cell Commun Signal       Date:  2014-10-30       Impact factor: 5.782

4.  5Z-7-Oxozeanol Inhibits the Effects of TGFβ1 on Human Gingival Fibroblasts.

Authors:  Hanna Kuk; James Hutchenreuther; Hannah Murphy-Marshman; David Carter; Andrew Leask
Journal:  PLoS One       Date:  2015-04-30       Impact factor: 3.240

5.  Yin/Yang expression of CCN family members: Transforming growth factor beta 1, via ALK5/FAK/MEK, induces CCN1 and CCN2, yet suppresses CCN3, expression in human dermal fibroblasts.

Authors:  Alexander Peidl; Bernard Perbal; Andrew Leask
Journal:  PLoS One       Date:  2019-06-06       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.